Clinical Trial Update: Sisonke (Together): OPEN LABEL TRIAL COVID-19 [Phase 3]

View source ↗

Summary

Open-label Phase 3 COVID-19 trial (Sisonke) has completed enrollment and status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Snippet

Sponsor: Wits Health Consortium (Pty) Ltd | Conditions: SARS (Severe Acute Respiratory Syndrome) | Phase 3 | Status: COMPLETED